INSILICO SALES ACHIEVEMENTS:• Acquired 5 major and 3 smaller biopharmaceutical companies as new customers since 2020, exceeding customer acquisition goal of 2 customers a year.• Increased company sales minimum 30% every year by developing innovative service projects and technology licensing agreements with new and existing customers.• Supervised management and performance of projects with 9 of Top 10 biopharmaceutical companies, leading cross-functional teams (technical and business colleagues) to deliver successful projects, resulting in 90% customer retention rate. • Increased revenue and acquired new customers by coordinating product management and R&D, and by creating sales strategy, to develop and launch innovative technology products: - Scaler Technology – Allows customers to scale products to manufacturing. - Insilico Suite – Platform that communicates with customer’s data management system.(CONTINUED)

(Provider of enterprise software solution which accelerates time-to-market solutions)• Launched United States subsidiary (Insilico Biotechnology Corporation) of Germany company (Insilico Biotechnology AG) (2020).• Hired Chief Financial Officer, legal consultants, and Business Development Representatives (BDRs) to establish US presence and sell Insilico technology and services to US biopharmaceutical market. • Created and implemented company-wide, high-throughput sales strategy and process which reduced sales cycle 3 months by:- Narrowing scope of qualified customers by focusing on V-level and D-level executives at only the Top 25 biopharmaceutical companies.- Removing intellectual property material during potential customer presentations, allowing for timely presentations versus waiting months for confidential disclosure agreements.- Changing process to establish leads with decision makers (EVPs, CTOs, CEOs) instead of Associate Scientists.• Developed pricing strategy for services and licensing products, established proposal creation framework, implemented project management tools, and created Excel forecasting tool.• Conduct presentations to explain Insilico technology and services, and uncover customer needs using consultative approach; develop customized proposal with solutions; present proposal to customer; gain customer agreement; and negotiate pricing and contract.• Work with in-house and outside legal counsel to secure Insilico intellectual property while negotiating customer agreements, and to review and execute contractual agreements (statement of works, master service agreements, licensing agreements).• Generate new business by attending conferences, presenting webinars, publishing articles, and contacting C-, V-, and D-level executives at biopharmaceutical companies.• Ensure BDRs achieve KPIs by training reps on sales strategy, sales process, and CRM; and by coaching reps after calls/meetings with potential customers.(CONTINUED)

• Oversee 4 to 5 projects per year for US biopharmaceutical companies by leading global team of colleagues (Germany, India, Singapore) to complete complex projects: - Service Projects – Utilize Insilico technology and customer data for virtual experimentation, allowing companies to scale to manufacturing without experiments in wet laboratory.- Technology Deployment Projects – Implement Insilico technology within customer’s data management system in customer’s facility with yearly licensing fee.• Support Marketing Team and Product Development Team with creating and revising marketing materials, presentations, and white papers used in product and sales campaigns.• Improve customer satisfaction by conveying realistic timelines with customer projects. • Provide comprehensive reports on sales forecasting and budgeting, sales strategy, and accounts. • Consolidate quarterly revenue and budgeting cycle for US subsidiary.• Supported coordination of multimillion-dollar acquisition of Insilico Biotechnology Corporation by Yokogawa Corporation (November 2021).

(Premier research center–affiliated with Harvard Medical School and MIT–devoted to development and application of advanced biomedical imaging technologies)• Performed daily synthesis of Positron Emission Tomography (PET) Radiotracers (C11, Cu64, and F18) used in clinical imaging using Explora FDG4 and Explora GN Modules. • Completed sterility and quality assurance of multiple daily Radiotracer doses. • Conducted daily System Suitability and produced master batch records for Radiotracer doses used to investigate and diagnose patient diseases, and for cardiac imaging.• Maintained operation of inline sensing instrumentation and modeling activities for Radiotracer production.• Earned Qualified Cleanroom Chemist Certification to work in cGMP- and FDA-compliant compounding facilities. • Trained extensively in High Performance Liquid Chromatography and Gas Chromatography. • Documented daily tasks, equipment operations, and production of chemicals. • Complied with laboratory SOPs, Good Manufacturing Practices, and company policies.• Coordinated external vendors in evaluating new technologies/instrumentations to implement.

• Managed $1.5M annual sales territory with 200+ Massachusetts accounts. • Monitored client accounts; developed forecasts; and tracked analytics for weekly, monthly, and annual reporting and review using healthcare software (Procura).• Increased client retention 25% by providing exceptional customer service; utilizing consultative selling to discover client concerns and develop action plans to address needs; and maintaining positive relationships with clients, staff, and referral sources.• Grew business volume minimum 10% annually by identifying and developing leads for new accounts and finding additional business at existing accounts.• Boosted referral business significantly by forming meaningful relationships with employees at hospitals, rehabilitation centers, law firms (estate planners), government elderly agencies, and Aging Services Access Points.• Reduced direct labor costs 15% and improved productivity for 100+ field employees by using advanced scheduling to decrease employee drive time and increase patient contacts.• Partnered with doctors, hospitals, long-term care and rehabilitation facilities, and Visiting Nursing Associations on program to reduce rehospitalization, which increased revenue by keeping customers using ABC services at home.• Strengthened company brand and augmented sales by designing innovative social media campaigns and by participating in trade shows.